Back
Day Range
$186.02
$189.40
52-Week Range
$95.49
$198.00
Volume
820,631
50D / 200D Avg
$173.53
/
$144.04
Prev Close
$185.01
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -32.7 | 0.3 |
| P/B | 2.7 | 3.0 |
| ROE % | -8.5 | 3.7 |
| Net Margin % | -8.4 | 3.8 |
| Rev Growth 5Y % | 8.4 | 10.0 |
| D/E | 1.3 | 0.2 |
Analyst Price Target
Hold
$207.86
+9.9%
Low: $170.00
High: $235.00
Forward P/E
7.90
Forward EPS
$23.93
EPS Growth (est.)
+0.0%
Est. Revenue
4.44B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$31.98
$30.75 – $33.42
|
6.02B | 2 |
| FY2029 |
$30.88
$29.69 – $32.27
|
5.76B | 2 |
| FY2028 |
$26.64
$19.61 – $32.84
|
5.18B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | $6.52 | $6.64 | +1.8% |
| 2025-11-05 | $5.95 | $8.13 | +36.6% |
| 2025-08-05 | -$6.12 | -$8.25 | -34.8% |
| 2025-05-06 | $4.51 | $1.68 | -62.7% |
| 2025-02-25 | $5.83 | $6.60 | +13.2% |
| 2024-11-06 | $5.47 | $6.61 | +20.8% |
| 2024-07-31 | $4.68 | $5.30 | +13.2% |
| 2024-05-01 | $4.14 | $2.68 | -35.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 8.37% annually over 5 years — modest growth
Earnings declined -163.58% over the past year
Generating 1.30B in free cash flow
PEG of 0.18 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.49%
Capital efficient — spends only 1.38% of revenue on capex
Growth
Revenue Growth (5Y)
8.37%
Revenue (1Y)4.88%
Earnings (1Y)-163.58%
FCF Growth (3Y)10.20%
Quality
Return on Equity
-8.47%
ROIC1.73%
Net Margin-8.35%
Op. Margin5.26%
Safety
Debt / Equity
1.26
Current Ratio1.86
Interest Coverage1.15
Valuation
P/E Ratio
-32.68
Forward P/E7.62
P/B Ratio2.70
EV/EBITDA69.83
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.88% | Revenue Growth (3Y) | 5.50% |
| Earnings Growth (1Y) | -163.58% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 8.37% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.27B | Net Income (TTM) | -356.15M |
| ROE | -8.47% | ROA | -3.05% |
| Gross Margin | 88.21% | Operating Margin | 5.26% |
| Net Margin | -8.35% | Free Cash Flow (TTM) | 1.30B |
| ROIC | 1.73% | FCF Growth (3Y) | 10.20% |
| Safety | |||
| Debt / Equity | 1.26 | Current Ratio | 1.86 |
| Interest Coverage | 1.15 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -32.68 | Forward P/E | 7.62 |
| P/B Ratio | 2.70 | P/S Ratio | 2.73 |
| PEG Ratio | 0.18 | Forward PEG | N/A |
| EV/EBITDA | 69.83 | Fwd EV/EBITDA | 11.68 |
| Forward P/S | 2.62 | Fwd Earnings Yield | 13.12% |
| FCF Yield | 11.14% | ||
| Market Cap | 11.64B | Enterprise Value | 15.67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.27B | 4.07B | 3.83B | 3.66B | 3.09B |
| Net Income | -356.15M | 560.12M | 414.83M | -224.06M | -328.95M |
| EPS (Diluted) | -5.84 | 8.65 | 6.10 | -3.58 | -5.51 |
| Gross Profit | 3.76B | 3.62B | 3.40B | 3.12B | 2.65B |
| Operating Income | 224.42M | 716.63M | 578.58M | -65.53M | 170.28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11.66B | 12.01B | 11.39B | 10.84B | 12.30B |
| Total Liabilities | 7.34B | 7.92B | 7.66B | 7.75B | 8.33B |
| Shareholders' Equity | 4.32B | 4.09B | 3.74B | 3.09B | 3.97B |
| Total Debt | 5.42B | 6.16B | 5.79B | 5.81B | 6.15B |
| Cash & Equivalents | 1.39B | 2.41B | 1.51B | 881.48M | 591.45M |
| Current Assets | 4.17B | 4.63B | 3.44B | 2.61B | 2.61B |
| Current Liabilities | 2.24B | 1.04B | 1.54B | 933.19M | 809.30M |